β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice

Andrew Kim, Kelly Morgan, Diane E. Hasz, Stephen M. Wiesner, Jennifer O. Lauchle, Jennifer L. Geurts, Miechaleen D. Diers, Doan T. Le, Scott C. Kogan, Luis F. Parada, Kevin Shannon, David A. Largaespada

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Neurofibromatosis type 1 (NF1) syndrome is caused by germline mutations in the NF1 tumor suppressor, which encodes neurofibromin, a GTPase activating protein for Ras. Children with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML) and lethally irradiated mice given transplants with homozygous Nf1 mutant (Nf1-/-) hematopoietic stem cells develop a fatal myeloproliferative disorder (MPD) that models JMML. We investigated the requirement for signaling through the GM-CSF receptor to initiate and sustain this MPD by generating Nf1 mutant hematopoietic cells lacking the common β chain (Beta c) of the GM-CSF receptor. Mice reconstituted with Nf1 -/-, beta c-/- stem cells did not develop evidence of MPD despite the presence of increased number of immature hematopoietic progenitors in the bone marrow. Interestingly, when the Mx1-Cre transgene was used to inactivate a conditional Nf1 mutant allele in hematopoietic cells, concomitant loss of beta c-/- reduced the severity of the MPD, but did not abrogate it. Whereas inhibiting GM-CSF signaling may be of therapeutic benefit in JMML, our data also demonstrate aberrant proliferation of Nf1-/- myeloid progenitors that is independent of signaling through the GM-CSF receptor.

Original languageEnglish (US)
Pages (from-to)1687-1691
Number of pages5
JournalBlood
Volume109
Issue number4
DOIs
StatePublished - Feb 15 2007

Fingerprint

Granulocyte-Macrophage Colony-Stimulating Factor Receptors
Myeloproliferative Disorders
Juvenile Myelomonocytic Leukemia
Neurofibromatosis 1
Stem cells
Neurofibromin 1
GTPase-Activating Proteins
Transplants
Granulocyte-Macrophage Colony-Stimulating Factor
Neurofibromatoses
Germ-Line Mutation
Tumors
Bone
Hematopoietic Stem Cells
Transgenes
Stem Cells
Bone Marrow
Alleles
Neoplasms

ASJC Scopus subject areas

  • Hematology

Cite this

Kim, A., Morgan, K., Hasz, D. E., Wiesner, S. M., Lauchle, J. O., Geurts, J. L., ... Largaespada, D. A. (2007). β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. Blood, 109(4), 1687-1691. https://doi.org/10.1182/blood-2006-05-025395

β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. / Kim, Andrew; Morgan, Kelly; Hasz, Diane E.; Wiesner, Stephen M.; Lauchle, Jennifer O.; Geurts, Jennifer L.; Diers, Miechaleen D.; Le, Doan T.; Kogan, Scott C.; Parada, Luis F.; Shannon, Kevin; Largaespada, David A.

In: Blood, Vol. 109, No. 4, 15.02.2007, p. 1687-1691.

Research output: Contribution to journalArticle

Kim, A, Morgan, K, Hasz, DE, Wiesner, SM, Lauchle, JO, Geurts, JL, Diers, MD, Le, DT, Kogan, SC, Parada, LF, Shannon, K & Largaespada, DA 2007, 'β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice', Blood, vol. 109, no. 4, pp. 1687-1691. https://doi.org/10.1182/blood-2006-05-025395
Kim A, Morgan K, Hasz DE, Wiesner SM, Lauchle JO, Geurts JL et al. β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. Blood. 2007 Feb 15;109(4):1687-1691. https://doi.org/10.1182/blood-2006-05-025395
Kim, Andrew ; Morgan, Kelly ; Hasz, Diane E. ; Wiesner, Stephen M. ; Lauchle, Jennifer O. ; Geurts, Jennifer L. ; Diers, Miechaleen D. ; Le, Doan T. ; Kogan, Scott C. ; Parada, Luis F. ; Shannon, Kevin ; Largaespada, David A. / β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. In: Blood. 2007 ; Vol. 109, No. 4. pp. 1687-1691.
@article{e7ee40b5ec0846af837f49a50fa167de,
title = "β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice",
abstract = "Neurofibromatosis type 1 (NF1) syndrome is caused by germline mutations in the NF1 tumor suppressor, which encodes neurofibromin, a GTPase activating protein for Ras. Children with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML) and lethally irradiated mice given transplants with homozygous Nf1 mutant (Nf1-/-) hematopoietic stem cells develop a fatal myeloproliferative disorder (MPD) that models JMML. We investigated the requirement for signaling through the GM-CSF receptor to initiate and sustain this MPD by generating Nf1 mutant hematopoietic cells lacking the common β chain (Beta c) of the GM-CSF receptor. Mice reconstituted with Nf1 -/-, beta c-/- stem cells did not develop evidence of MPD despite the presence of increased number of immature hematopoietic progenitors in the bone marrow. Interestingly, when the Mx1-Cre transgene was used to inactivate a conditional Nf1 mutant allele in hematopoietic cells, concomitant loss of beta c-/- reduced the severity of the MPD, but did not abrogate it. Whereas inhibiting GM-CSF signaling may be of therapeutic benefit in JMML, our data also demonstrate aberrant proliferation of Nf1-/- myeloid progenitors that is independent of signaling through the GM-CSF receptor.",
author = "Andrew Kim and Kelly Morgan and Hasz, {Diane E.} and Wiesner, {Stephen M.} and Lauchle, {Jennifer O.} and Geurts, {Jennifer L.} and Diers, {Miechaleen D.} and Le, {Doan T.} and Kogan, {Scott C.} and Parada, {Luis F.} and Kevin Shannon and Largaespada, {David A.}",
year = "2007",
month = "2",
day = "15",
doi = "10.1182/blood-2006-05-025395",
language = "English (US)",
volume = "109",
pages = "1687--1691",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice

AU - Kim, Andrew

AU - Morgan, Kelly

AU - Hasz, Diane E.

AU - Wiesner, Stephen M.

AU - Lauchle, Jennifer O.

AU - Geurts, Jennifer L.

AU - Diers, Miechaleen D.

AU - Le, Doan T.

AU - Kogan, Scott C.

AU - Parada, Luis F.

AU - Shannon, Kevin

AU - Largaespada, David A.

PY - 2007/2/15

Y1 - 2007/2/15

N2 - Neurofibromatosis type 1 (NF1) syndrome is caused by germline mutations in the NF1 tumor suppressor, which encodes neurofibromin, a GTPase activating protein for Ras. Children with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML) and lethally irradiated mice given transplants with homozygous Nf1 mutant (Nf1-/-) hematopoietic stem cells develop a fatal myeloproliferative disorder (MPD) that models JMML. We investigated the requirement for signaling through the GM-CSF receptor to initiate and sustain this MPD by generating Nf1 mutant hematopoietic cells lacking the common β chain (Beta c) of the GM-CSF receptor. Mice reconstituted with Nf1 -/-, beta c-/- stem cells did not develop evidence of MPD despite the presence of increased number of immature hematopoietic progenitors in the bone marrow. Interestingly, when the Mx1-Cre transgene was used to inactivate a conditional Nf1 mutant allele in hematopoietic cells, concomitant loss of beta c-/- reduced the severity of the MPD, but did not abrogate it. Whereas inhibiting GM-CSF signaling may be of therapeutic benefit in JMML, our data also demonstrate aberrant proliferation of Nf1-/- myeloid progenitors that is independent of signaling through the GM-CSF receptor.

AB - Neurofibromatosis type 1 (NF1) syndrome is caused by germline mutations in the NF1 tumor suppressor, which encodes neurofibromin, a GTPase activating protein for Ras. Children with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML) and lethally irradiated mice given transplants with homozygous Nf1 mutant (Nf1-/-) hematopoietic stem cells develop a fatal myeloproliferative disorder (MPD) that models JMML. We investigated the requirement for signaling through the GM-CSF receptor to initiate and sustain this MPD by generating Nf1 mutant hematopoietic cells lacking the common β chain (Beta c) of the GM-CSF receptor. Mice reconstituted with Nf1 -/-, beta c-/- stem cells did not develop evidence of MPD despite the presence of increased number of immature hematopoietic progenitors in the bone marrow. Interestingly, when the Mx1-Cre transgene was used to inactivate a conditional Nf1 mutant allele in hematopoietic cells, concomitant loss of beta c-/- reduced the severity of the MPD, but did not abrogate it. Whereas inhibiting GM-CSF signaling may be of therapeutic benefit in JMML, our data also demonstrate aberrant proliferation of Nf1-/- myeloid progenitors that is independent of signaling through the GM-CSF receptor.

UR - http://www.scopus.com/inward/record.url?scp=33846902274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846902274&partnerID=8YFLogxK

U2 - 10.1182/blood-2006-05-025395

DO - 10.1182/blood-2006-05-025395

M3 - Article

C2 - 17090653

AN - SCOPUS:33846902274

VL - 109

SP - 1687

EP - 1691

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -